AROW
Arrow Financial Corporation
AROW offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over AROW overall, supported by stronger fundamentals and stronger modeled upside.
AROW Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
AROW's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AROW.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
AROW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.3x | $38.68 | — |
| Cheap | 11x | $29.38 | -24% |
| Fair | 13x | $33.92 | -12% |
| Expensive | 15x | $39.77 | +2.8% |
| Current | 15x | $38.68 | — |
Historical ranges are pointers, not guarantees.
AROW's PE is in its expensive range at 15x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over AROW in the historical PE scenario, which offers more potential upside but is not a forecast.
AROW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for AROW, but weaker profitability.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
AROW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.16 | +58% |
| Q3 2026 | $2.64 | +28% |
| Q2 2026 | $3.10 | +69% |
| Q1 2026 | $3.09 | +82% |
| Q4 2025 | $2.65 | +50% |
| Q3 2025 | $2.07 | +7.3% |
| Q2 2025 | $1.83 | -1.6% |
| Q1 2025 | $1.70 | +0.6% |
| Q4 2024 | $1.77 | +1.7% |
AROW earned $2.64 per share over the past year, up 28% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
AROW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2024 | $35M | +7.1% |
| Q1 2024 | $34.3M | -1.3% |
| Q4 2023 | $33.1M | -12% |
| Q3 2023 | $33.4M | -14% |
| Q2 2023 | $32.7M | -11% |
| Q1 2023 | $34.8M | -3.4% |
| Q4 2022 | $37.7M | +8.5% |
| Q3 2022 | $38.7M | +6.6% |
JPM has the stronger quarterly revenue trend. Revenue is up 7.1% for AROW versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2019 | 41% | N/A |
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
AROW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.8M | +31% |
| Q2 2026 | $11.6M | +40% |
| Q1 2026 | $13.9M | +58% |
| Q4 2025 | $4.8M | +18% |
| Q3 2025 | $14.3M | +77% |
| Q2 2025 | $8.3M | +10% |
| Q1 2025 | $8.8M | -4.3% |
| Q4 2024 | $4.1M | +$21M |
AROW has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
AROW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +12% | +2M shares |
| 1 year | +13% | +2.1M shares |
| 3 years | +8.3% | +1.4M shares |
| 5 years | +8.2% | +1.4M shares |
| Available history | +9.5% | +1.6M shares |
AROW has 18M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1M |
| Q2 2026 | $370,000 |
| Q1 2026 | $113,000 |
| Q4 2025 | $154,000 |
| Q3 2025 | $1.4M |
| Q2 2025 | $5.2M |
| Q1 2025 | $3.5M |
| Q4 2024 | $265,000 |
AROW spent $2M buying back its own shares over the past year, down 84% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over AROW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
AROW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | 3.1x | Elevated |
AROW's net debt is about 3.1 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like AROW.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
AROW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.7 | Neutral |
| Stochastic | 55.0 | Neutral |
AROW's weekly RSI is 55 (neutral) and its Stochastic is 55 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
AROW PE vs Financial Services Sector
| Metric | AROW | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 13% above |
| PE % | 77 | 63 | 14 pts above |
AROW is trading at 15x earnings, a 13% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over AROW on valuation relative to its sector.
AROW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.8 | 2.3% above |
| 20 week MA | $38.9 | 0.5% below |
| 50 week MA | $36.4 | 6.2% above |
| 100 week MA | $31.8 | 22% above |
| 200 week MA | $28.4 | 36% above |
AROW's trend is mixed: it's above four of its five weekly moving averages, and 36% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
AROW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.4 | $29.4 | -19% |
| 2021 | $29.4 | $34.2 | +17% |
| 2022 | $34.2 | $34.4 | +0.4% |
| 2023 | $34.4 | $27.9 | -19% |
| 2024 | $27.9 | $28.5 | +2% |
| 2025 | $28.5 | $31.5 | +10% |
| 2026 YTD | $31.5 | $38.7 | +23% |
AROW has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.